A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

Recruiting

Phase 3

CagriSemaA Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

Sponsor:

Novo Nordisk A/S

Code:

NCT06780449

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cagrilintide

Semaglutide

Placebo cagrilintide

Placebo semaglutide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-10. This information was provided to ClinicalTrials.gov by Novo Nordisk A/S on 2025-08-27.